Research

We offer products with clinically proven effectiveness

VagiVital has undergone a multicenter clinical study designed according to FDA guidelines with 90 patients documenting safety and positive results.

Behind the study is a group of female researchers (professors and practicing gynecologists) from Karolinska University Hospital, Akademiska Hospital in Uppsala, and Umeå University Hospital. All are passionate about promoting women's health, and that was what drove the clinical study to show such good results. A total of 79% of patients experienced complete relief or a significant improvement in their most persistent symptoms. VagiVital has been designated as a therapeutic vaginal gel because it has been shown to do much more than just moisturize. The following results have been proven:

• Complete relief or significant improvement of the most common symptoms (itching, irritation, tingling, discomfort during intercourse or urination)
• Reduced urgency to urinate
• Improvement of vaginal pH and increase of superficial cells in the vaginal tissue

The positive effects of VagiVital are on par with those reported for most estrogen preparations, with one important difference: VagiVital is completely hormone-free.

Customer Survey

In July 2018, VagiVital conducted a customer survey on the Swedish market to evaluate how well the product had worked for people since its release. 210 women who had used VagiVital for at least one month received a digital customer survey and answered a number of questions about their experiences with the product. Participants were also asked to express their experience of the applicator and respond to how easy the instructions were to follow.

The survey showed that since its launch, VagiVital has proven to be safe, effective, and 81% of participants had experienced significant improvements in their most troublesome symptoms.

It was also clear that the longer they had used VagiVital, the more improvement they saw. Of those who used VagiVital for 2 months or longer, 89% had experienced significant symptom relief. These results are in line with VagiVital's previous clinical studies.

Below is the number of women who experienced symptomatic relief after using VagiVital for:

• One month - 77%
• More than 2 months - 89%

85% of women would recommend VagiVital to someone they know.
Download customer survey: CUSTOMER SURVEY 2019 CUSTOMER SURVEY 2020 CUSTOMER SURVEY 2021

RESEARCH FOR CHANGE!

We are constantly working to improve equality in research funding, where focus on women's health should also be prioritized. Please support women's vaginal health research by signing our petition here.

VagiVital works to raise money for independent research on women's health. Our mission is supported by Associate Professor Aino Fianu Jonasson, Karolinska University Hospital, as well as by Professor Inger Sundström Poromaa, Uppsala University Hospital. 1% of all VagiVital sales go to the 1.6 Million Club, an organization dedicated to funding research on women's health. By purchasing this product, you support us in our mission to increase focus on women's health and the conversations around it.